Sugi Predict

Sugi Predict / Compounds / 1-Ethylquinolonium

1-Ethylquinolonium

1-Ethylquinolonium

SCHEMBL309459

CC[n+]1cccc2ccccc21

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 13/20 0.63
▸ BCHE P06276 12/20 0.63
▸ KDM4E B2RXH2 1/20 0.59
▸ MEN1 O00255 1/20 0.59
▸ RGS12 O14924 1/20 0.59
▸ NPC1 O15118 1/20 0.59
▸ USP2 O75604 1/20 0.59
▸ LMNA P02545 1/20 0.59
▸ HSP90AA1 P07900 1/20 0.59
▸ THRB P10828 1/20 0.59
▸ MAPK1 P28482 1/20 0.59
▸ HTT P42858 1/20 0.59
▸ RAD52 P43351 1/20 0.59
▸ RAB9A P51151 1/20 0.59
▸ KMT2A Q03164 1/20 0.59
▸ MCL1 Q07820 1/20 0.59
▸ SMN1; SMN2 Q16637 1/20 0.59
▸ NPSR1 Q6W5P4 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
1-Ethylquinolonium SCHEMBL30920082 0.98 KDM4E (0.62) ACHEBCHEKDM4EMEN1RGS12
1-Ethylquinolonium SCHEMBL9135771 0.98 ACHE (0.62) ACHEBCHEKDM4EMEN1RGS12
1-Ethylquinolonium SCHEMBL18804795 0.98 ACHE (0.61) ACHEBCHEKDM4EMEN1RGS12
1-Ethylquinolonium SCHEMBL186988 0.98 KDM4E (0.62) ACHEBCHEKDM4EMEN1RGS12
1-Ethylquinolonium SCHEMBL10655763 0.98 ACHE (0.64) ACHEBCHE
1-Ethylquinolonium SCHEMBL28221155 0.92 ACHE (0.55) ACHEBCHEKDM4EMEN1RGS12
1-Ethylquinolonium SCHEMBL4624855 0.92 ACHE (0.55) ACHEBCHEKDM4EMEN1RGS12
1-Ethylquinolonium SCHEMBL29623615 0.90 ACHE (0.53) ACHEBCHEKDM4EMEN1RGS12
1-Ethylquinolonium SCHEMBL9645182 0.87 ACHE (0.50) ACHEBCHEKDM4EMEN1RGS12
1-Ethylquinolonium SCHEMBL8568032 0.84 KDM4E (0.58) ACHEBCHEKDM4EMEN1RGS12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 430 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104447537-B A kind of 3,3 '-methylene containing ethyl quinolinium ring-bis-fluoro quinolone derivatives and its preparation method and application 河南大学 2016-08-24 — — CN claimed
CN-103435456-B Preparation method for 9-fluorenone BAOSHUN TECHNOLOGY CO LTD 2015-06-10 — — CN claimed
CN-104492463-A TiO2/ AC-SO42-solid acid photocatalyst and application thereof UNIV NINGXIA 2015-04-08 — — CN claimed
CN-104447537-A 3,3'-methylene-bisfluoroquinolone derivative containing ethylquinoline rings as well as preparation method and application thereof UNIV HENAN 2015-03-25 — — CN claimed
US-8436055-B2 Modified acidic ion-exchange resin and method for preparing bisphenol MITSUI CHEMICALS, INC. (JP) 2013-05-07 — — US claimed
US-20100324341-A1 MODIFIED ACIDIC ION-EXCHANGE RESIN AND METHOD FOR PREPARING BISPHENOL TERAJIMA TAKASHI 2010-12-23 — — US claimed
EP-1908519-B1 Method for preparing bisphenol in the presence of a modified acidic ion-exchange resin MITSUI CHEMICALS INC (JP) 2010-07-14 — — EP claimed
EP-1908519-A1 Method for preparing bisphenol in the presence of a modified acidic ion-exchange resin Mitsui Chemicals, Inc. (JP) 2008-04-09 — — EP claimed
US-5492652-A Dithiopentacene derivatives, their preparation and the use thereof as electron acceptors in charge transfer complexes CIBA-GEIGY CORPORATION (US) 1996-02-20 — — US claimed
US-5393606-A Electroconductivity CIBA-GEIGY CORPORATION (US) 1995-02-28 — — US claimed
EP-0588759-A1 Dithiopentacene derivatives, their preparation and their use in charge-transfer complexes CIBA-GEIGY AG (CH) 1994-03-23 — — EP claimed
EP-0573387-A2 Charge-transfer complex with N-aromatic compounds, their preparation and their use CIBA-GEIGY AG (CH) 1993-12-08 — — EP claimed
US-4885368-A SEMICONDUCTORS, PHOTOCONDUCTORS, ELECTRODES, BATTERIES BASF AKTIENGESELLSCHAFT (DE) 1989-12-05 — — US claimed
EP-0206266-B1 RADICAL-ION SALTS BASF Aktiengesellschaft (DE) 1989-08-23 — — EP claimed
US-4792644-A ZEOLITE AND QUATERNARY AMMONIUM SALT TOSOH CORPORATION (JP) 1988-12-20 — — US claimed
EP-0293749-A1 N,N'-Biscyano-p-benzoquinonebisimines, charge-transfer complexes containing them and radical-ion salts of the biscyano-benzoquinonebisimines BASF Aktiengesellschaft (DE) 1988-12-07 — — EP claimed
EP-0206266-A2 Radical-ion salts BASF Aktiengesellschaft (DE) 1986-12-30 — — EP claimed
EP-0197775-A2 Synthesis of large crystal zeolite ZSM-5 MOBIL OIL CORPORATION (US) 1986-10-15 — — EP claimed
EP-0039842-A1 Improvements in or relating to smoking compositions PHILIP MORRIS INCORPORATED (US) 1981-11-18 — — EP claimed
US-4225497-A ACID CATALYSTS FOR IMIDATION RHONE-POULENC INDUSTRIES (FR) 1980-09-30 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100324341-A1 MODIFIED ACIDIC ION-EXCHANGE RESIN AND METHOD FOR PREPARING BISPHENOL PTMS, PHOSPHO1, ELL ACHE 4318/4885BCHE 2549/4885KDM4E 150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.